Note s4
121 subscribers
329 photos
69 files
77 links
Download Telegram
๐Ÿ”–ูŠู„ุง ู†ูƒู…ู„ ู…ุฑุงุฌุนุฉ ุงู„ู„ูƒุฌุฑ ุงู„ุซุงู„ุซ ู„ู…ุงุฏุฉ ุงู„ูุงุฑู…ุง ๐Ÿ’Š๐Ÿ’Š

โฌ…๏ธุงุญู†ุง ุฑุงุฌุนู†ุง ุจุดูƒู„ ุจุณูŠุท ุฌุฒุก ุงู„ DMARDs ูู‡ุณุฉ ู†ุจู„ุด ุจุงู„ุฌุฒุก ุงู„ุซุงู†ูŠ
ูˆู‡ูˆ ุงู„ Gout โœ…

๐Ÿ“Œุงูˆู„ ุดูŠ ุงู„ู†ู‚ุฑุต ูŠูƒูˆู† ุจุณุจุจ ุฒูŠุงุฏุฉ ู…ุณุชูˆู‰ ุงู„ uric acid ุจุงู„ุฏู… ูˆู‡ุฐุง ุงู„ุดูŠ ุญูŠุคุฏูŠ ุงู„ู‰ โฌ‡๏ธโฌ‡๏ธ

Deposition of sodium urate crystals in tissue
ุฎุงุตุฉ ุงู„ูƒู„ู‰ ูˆุงู„ู…ูุงุตู„ โ˜น๏ธ
ูˆูŠุจุฏูŠ ุจุนุฏู‡ุง ุงู„ Inflammation ๐Ÿ˜•

ูˆุงู„ hyperuricemia ู‡ูˆ ุฏูŠุตูŠุฑ ู†ุชูŠุฌุฉ โฌ‡๏ธ

Imbalance between overproduction of uric acid and or inability to excrete uric acid renally

ูˆุงุฏูˆูŠุฉ ุงู„ gout ุงูƒุซุฑู‡ุง ุญุชู‚ู„ู„ ู…ุณุชูˆู‰ ุงู„ uric acid ุงู„ู‰ ุงู‚ู„ ู…ู† ๐Ÿ‘‡
                      6 mg/dl

๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”
ู‡ุณุฉ ุงู„ุณุคุงู„ ุดู„ูˆู† ุฑุงุญ ู†ุนุงู„ุฌ ุงู„
Acute gouty attack
ูˆุดู„ูˆู† ุญู†ุนุงู„ุฌ ุงู„ Chronic ๐Ÿค”

๐Ÿ“ฅTreatment fot acute gout are

๐ŸŒŸNSAIDs
๐ŸŒŸCorticosteroids
๐ŸŒŸColchicine 

ูˆู†ุชุฐูƒุฑ ุงู† ุงู„ Colchicine
ู‡ูˆ ู„ุง uricosuric ูˆู„ุง ุญุชู‰ analgesic ๐Ÿค“
ุจุณ ู…ุน ุฐู„ูƒ ู‡ูˆ ๐Ÿ‘‡
Relieves pain in acute attack

ุฒูŠู† ุดู„ูˆู† ๐Ÿค”ุŸ
ุงู„ู…ูŠูƒุงู†ุฒู… ู…ุงู„ุชู‡ ูƒุงู„ุชุงู„ูŠ ๐Ÿ‘‡
๐ŸŒŸBind to tubutlin causing depolymerization
๐ŸŒŸThis disrupts cellular function
๐ŸŒŸDecreasing their migration into inflamed tissue

๐ŸŒŸAlso block cell devision by binding to mitotic spindle

๐Ÿ‘ˆุฒูŠู† ุณุคุงู„ ู‡ู„ ุงุญู†ุง ู†ุณุชุฎุฏู… ุงู„ NSAIDs ู„ูˆ Colchicine ู„ู„ Acute ๐Ÿง

ุงุญู†ุง ู†ุณุชุฎุฏู… ุงูŠ ุงุญุฏ ุจูŠู‡ู… ุงูƒูŠุฏ ู„ูƒู† ุงุญู†ุง ุงุณุชุจุฏู„ู†ุง ุงู„ colchicine ุจุงู„ NSAIDs ู„ุงุณุจุงุจ ุชุชุนู„ู‚ ุจุงู„ุงู…ุงู† ๐Ÿ˜‰

ุฒูŠู† ู…ู…ูƒู† ู†ุณุชุฎุฏู… ุงู„ colchicine ูƒุนู„ุงุฌ ูˆู‚ุงุฆูŠ ๐Ÿคจ
Yes , Yes , yes , yes โœ”๏ธโœ”๏ธโœ”๏ธ

๐Ÿ’กุชุฐูƒุฑ ุงู† ุงู„ colchicine ุญุชู‰ ูŠูƒูˆู† ูุนุงู„ ูŠุญุชุงุฌ ู†ู†ุทูŠู‡ ู‚ุจู„ 36 ุณุงุนุฉ  ู…ู† ุงู„
onset of attack


๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”

๐Ÿ“ฅ Treatment of chronic gout are
๐ŸŒŸ Allopurinol
๐ŸŒŸ Febuxostat
๐ŸŒŸ Probenecid
๐ŸŒŸ Pegloticase

ุจุณ ุงุฎุฑ ุงุซู†ูŠู† ุงุญู†ุง ุฑุงุญ ู†ุณุชุฎุฏู…ู‡ู… ุจุญุงู„ุงุช ู…ุนูŠู†ุฉ ู„ุฐู„ูƒ ุงู„ุงุฏูˆูŠุฉ ุงู„ุงุณุงุณูŠุฉ ุงู„ู„ูŠ ุญู†ุณุชุฎุฏู…ู‡ุง ุจุงู„ุจุฏุงูŠุฉ ู‡ู…

โžก๏ธFirst line urate lowering agent
๐ŸŒŸ Allopurinol
๐ŸŒŸ Febuxostat
  
ู‡ุฐูˆู„ุง ุงู„ุซู†ูŠู† ูŠุดุชุบู„ูˆู† โฌ‡๏ธ
Act as Xanthin oxidase inhibitor

ุฒูŠู† ุงุฐุง ุงู„ู…ุฑูŠุถ ู…ุงูŠูƒุฏุฑ ูŠุชุญู…ู„ ู‡ุฐู‡ ุงู„ุงุฏูˆูŠุฉ ุงูˆ ุชุนุงู„ุฌ ุจูŠู‡ุง ุจุณ ูุดู„ ุงู„ุนู„ุงุฌ ูˆู…ุงุณุชุฌุงุจ ุงู„ู‡ ุดู†ูˆ ุงู„ุนู„ุงุฌ ุงู„ุจุฏูŠู„ โฌ‡๏ธโฌ‡๏ธ

Probencid ( uricosuric agent )
ูˆุจุนุฏ

๐Ÿ’ฌPegloticase is indicated to pt with gout who fail treatment with xanthin oxidase inhibitor

ูŠุนู†ูŠ ุงุฎุฑ ุงุซู†ูŠู† ุงุญู†ุง ู†ุณุชุฎุฏู…ู‡ู… ุงุฐุง ูุดู„ูˆุง ุงูˆู„ ุงุซู†ูŠู† ุจุนู„ุงุฌ ุงู„ู…ุฑูŠุถ ๐Ÿ™‚
๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”

๐Ÿ“ฅMechanism of action

1โƒฃ  Allopurinol
๐ŸŒŸ Xanthin oxidase inhibitor
๐ŸŒŸ reduce production of uric acid by competetively inhibit last 2 steps in uric acid synthesis

2โƒฃ Febuxostat

๐ŸŒŸ Xanthin oxidase inhibitor 

3โƒฃ Probenecid

๐ŸŒŸIt is uricosuric agent
๐ŸŒŸIt is weak organic acid that promote renal clearance of uric acid by inhibitng urate anion exchanger in the proximal tubule

๐ŸŒŸ At therapeutic dose it block tubular reabsorption of uric acid


4โƒฃ Pegloticase

๐ŸŒŸ Convert  uric acid to allantoin , a water soluble nontoxic metabolite excreted by kidney

ูˆู†ุชุฐูƒุฑ ุงู† ู‡ุฐุง ุงู„ุฏูˆุง ู‡ูˆ ุนุจุงุฑุฉ ุนู† โฌ‡๏ธโฌ‡๏ธ
Recombinant form of urate oxidase or uricase enzyme


#DMARDs
๐Ÿ“ฅู†ูƒู…ู„ ูƒู„ Pharmacokinetics ู„ุงุฏูˆูŠุฉ ุงู„ Gout

โœจู…ุจุฏุฆูŠุง ูƒู„ู‡ู… ูŠู†ุฃุฎุฐูˆู† Orally ุนุฏุง
ุงู„ Pegloticase ู†ุงุฎุฐู‡ โฌ‡๏ธโฌ‡๏ธ

IV infusion every 2 weeks

๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”
โœจ ู…ู†ูˆ ูŠุทู„ุน ุนู† ุทุฑูŠู‚ ุงู„ูƒุจุฏ ูˆู…ู†ูˆ ุนู† ุทุฑูŠู‚ ุงู„ูƒู„ู‰ โ‰๏ธ


1โƒฃColchicine
โœ…ุงูˆู„ ุดูŠ ุนุฏู†ุง ุงู„ Colchicine ู‡ุฐุง ูŠุตูŠุฑู„ู‡ metabolism  ุจุงู„ูƒุจุฏ ุจุงู„ CYP450 , 3A4 ูˆุฌุฒุก ู…ู†ู‡ ูŠุทู„ุน ุนู† ุทุฑูŠู‚ ุงู„ูƒู„ู‰ โœ”๏ธ

ุฒูŠู† ู†ุญุชุงุฌ ู†ุนุฏู„ ุงู„ุฌุฑุนุฉ ูˆ ุจู…ุฑูŠุถ ุงู„ูƒู„ู‰ ู„ูˆ ุงู„ูƒุจุฏ ุŸ
ู†ุนู… ู†ุญุชุงุฌ ู†ุนุฏู„ ุงู„ุฌุฑุนุฉ ุจุงู„ ๐Ÿ‘‡
Severe renal impairment
ูˆุจุนุฏ ุŸ 

ูˆูŠุง ุงุฏูˆูŠุฉ ุชุฃุซุฑ ุนู„ู‰ ุงู†ุฒูŠู… ุงู„ CYP3A4 ู‡ู… ูŠุญุชุงุฌ ู†ุนุฏู„ ุงู„ุฌุฑุนุฉ ุงุฐุง ุงุฎุฐู†ุงู‡ ูˆูŠุงู‡ู… ูˆุญู†ุฐูƒุฑ ุงู„ุงุฏูˆูŠุฉ ุงุฎุฑ ุดูŠ ูˆูŠุง ุงู„ุชุฏุงุฎู„ุงุช ๐Ÿ‘
2โƒฃ Allopurinol
๐ŸŒŸExcreted in the urine ๐Ÿ˜

ูˆูŠุญุชุงุฌ ู†ุนุฏู„ ุงู„ุฌุฑุนุฉ ุงุฐุง ูˆุตู„ ุงู„ โฌ‡๏ธ
GFR less than 30ml/min


3โƒฃ Febuxostat
Dosen't have the same degree of renal elminiation of allopurinol

ู„ูƒู† ู‡ู… ูŠุญุชุงุฌ ุชุนุฏูŠู„ ู„ู„ุฌุฑุนุฉ ุจุณ ุจุดูƒู„ ุงู‚ู„ ุจุงู„ู…ุฑุถู‰ ุงู„ู„ูŠ ุนุฏู‡ู… โฌ‡๏ธโฌ‡๏ธ
Reduced renal function



4โƒฃPegloticase
๐ŸŒŸ Excreted primarily by kidney



๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”
Contraindication

๐Ÿ’กุชุฐูƒุฑ ุงู† ุงู„ Febuxostat ู„ุงุฒู… ู†ุชุฌู†ุจู‡ ุจู…ุฑุถู‰ ุงู„ู‚ู„ุจ ุงูˆ ุงู„ุณูƒุชุฉ ุงู„ุฏู…ุงุบูŠุฉ โŒโŒ

๐Ÿ’ก
ูˆุชุฐูƒุฑ ุงู† ุงู„ Probenecid ู†ุชุฌู†ุจู‡ ุชู…ุงู…ุง โŒโŒ

ุงุฐุง ู‚ู„ ุงู„ Creatinin clearance ุงู„ู‰ ุงู‚ู„ ู…ู†
50 ml/min

๐Ÿ’ก ู„ุงูŠุนุทู‰ ุงู„ Colchicine ู„ู„ุญุงู…ู„ โŒ
ูˆู†ุนุทูŠู‡ ุจุญุฐุฑ ู„ู…ุฑุถู‰ ุงู„ูƒู„ู‰ ูˆุงู„ูƒุจุฏ ูˆุงู„ู‚ู„ุจ โš ๏ธ


#DMARDs
#๏ธโƒฃ#๏ธโƒฃ ุฃู‡ู… ู…ุง ุจฺ†ุงุจุชุฑ 2๏ธโƒฃ ุชฺฏุฏุฑู‡ ุชุนุชู…ุฏู‡ ูˆุชุนุชุจุฑู‡ ู…ุฑุงุฌุนุฉ ู„ู‚ุฑุงูŠุชูƒ

๐ŸŸกCardiac effect:

โœ…ุงูˆู„ ุดูŠ ุฐุงูƒุฑ ูˆูƒู„ุณุงุน ูŠุนูŠุฏู‡ุง ู…ู„ูŠู†ุง ู…ู†ู‡ุง ุงู†ูˆ ุงู„ุฃุณุจุฑูŠู† ูŠุดุชุบู„ ุนู„ู‰ COX1 ูˆูŠุญู…ูŠู†ูŠ ู…ู† CV event ุจุณุจุจ ุชุซุจูŠุท THXA2

โœ…ูˆุงู„ุฃุฏูˆูŠุฉ ุงู„ู„ูŠ ุชุดุชุบู„ ุนู„ู‰ COX2 ุนุฏู‡ุง ู…ุฎุงุทุฑ ุชุณูˆูŠ CV event ุฃุนู„ู‰ ุจุณุจุจ ุชุซุจูŠุท PGI2 ุงู„ู„ูŠ ู…ุณุคูˆู„ ุนู† ู…ู†ุน ุงู„ุฌู„ุทุงุช ูˆุชูˆุณุนุฉ ุงู„ุฃูˆุนูŠุฉ

๐Ÿ’™ูƒู„ NSAIDS ูŠุณูˆูˆู„ูŠ ู…ุฎุงุทุฑ CV ุนุฏุง ุงู„ุฃุณุจุฑูŠู†

โšก๏ธุงู„ู…ุฑูŠุถ ุงู„ู„ูŠ ุนู†ุฏู‡ ุฃู…ุฑุงุถ ู‚ู„ุจ ูˆูŠุฑูŠุฏ ูŠุงุฎุฐ NSAIDS ุฃุฃู…ู† ุดูŠ ู‡ูˆ Naproxen + ุงู„ุฃุณุจุฑูŠู† ุจุงู„ุฌุฑุน ุงู„ู‚ู„ูŠู„ุฉ ุงู„ุจู‚ูŠุฉ ู…ู…ู†ูˆุน

๐Ÿ˜€side effects:
โš ๏ธุงู„ุดุฎุต ุงู„ุนู†ุฏู‡ ุญุณุงุณูŠุฉ ุนุงู„ูŠุฉ ุชุฌุงู‡ ุงู„ุฃุณุจุฑูŠู† ู…ู…ู†ูˆุน ู†ู†ุทูŠ NSAIDS

๐ŸŸ Drug interaction:
ุงู„ุฃุณุจุฑูŠู† (salicylate ) ูŠุฑุชุจุท ุจุงู„ุฃู„ุจูˆู…ูŠู† ุจู†ุณุจุฉ ูจู -ูฉู %
ูˆุนู†ุฏู‡ ู‚ุฏุฑุฉ ูŠุฒูŠุญ ุงู„ุฃุฏูˆูŠุฉ ุงู„ู„ูŠ ุชุฑุชุจุท ุจุงู„ุฃู„ุจูˆู…ูŠู† ู…ุซู„
phenytoin,warfarin,valproic acid


ุจุงู„ุชุงู„ูŠ ุชุฒุงุฏุงุฏ ู†ุณุจุชู‡ู… ุจุงู„ุฏู… ูˆุชุทู„ุน ุณุงูŠุฏ ุงููƒุช ู…ุงู„ุชู‡ู…

๐Ÿ›‘Toxicity:
๐Ÿ’กุฃุนุฑููˆ ุฃู† ุจุงู„ุฌุฑุน Mild salicylate ูŠุนู†ูŠ ู…ูˆ ุงู„ู‚ุงุชู„ุฉ ูŠุณู…ูˆู‡ salicylism ูˆุฃู‡ู… ุนุฑุถ ุจูŠู‡ุง ู‡ูˆ hyperventilation

๐Ÿ’กุจุณ ุจุงู„ู€ high dose of salicylate
ูŠุณูˆูŠู„ูŠ respiratory and metabolic acidosis
ุงู„ุฃุทูุงู„ ุฃูƒุซุฑ ุนุฑุถุฉ ูˆุงู„ุฌุฑุน ุงู„ู‚ุงุชู„ุฉ 10g

๐Ÿ”˜pregnancy:
ุฃุฃู…ู† ุดูŠ ู‡ูˆ Acetaminophen ูƒู€ ุฎุงูุถ ุญุฑุงุฑุฉ ูˆู…ุณูƒู†

โš ๏ธ ุฃุชุฌู†ุจ ุฅุนุทุงุก ุฃูŠ NSAIDS ููŠ ุงู„ุซู„ุซ ุงู„ุฃุฎูŠุฑ ู…ู† ุงู„ุญู…ู„ ู„ุฃู† ูŠุณูˆูŠ
Premature closure of ductus arteriousus

๐Ÿ›‘Selective COX2 Inhibitor:
ุฃู‡ู… ุฏูˆุงุก ู‡ูˆ celecoxib
ูˆูŠูƒูˆู† reversible Inhibitor
ูˆูŠุณุชุฎุฏู… ุจู€ RA,OA , Acute pain

ุชุนุฑู ุฃู†ูˆ ูŠุตูŠุฑ metabolism ุนู† ุทุฑูŠู‚ CYP2C9
ูˆ half-life ู…ุงู„ุชู‡ 11 ุณุงุนุฉ
ูŠู†ุทูŠ ู…ุฑุฉ ุงูˆ ู…ุฑุชูŠู† ุจุงู„ูŠูˆู…

๐Ÿ”ขุฅุฐุง ู…ุฑูŠุถ ุถุนู ุจุงู„ูƒุจุฏ moderate ุจุณ ุฃุนุฏู„ ุงู„ุฌุฑุน
๐Ÿ”ขุฅุฐุง sever hepatic or Renal disease ู…ู…ู†ูˆุน ุฃู†ุทูŠ โš ๏ธ
ุฃู‚ู„ GIT effects

ู…ู…ู†ูˆุน ุฃู†ุทูŠ ูˆูŠ ู…ุฑูŠุถ ุนู†ุฏู‡ ulcer ูˆูŠุงุฎุฐ ุฃุณุจุฑูŠู†โš ๏ธ

ู…ู…ูƒู† ูŠุฒุฏุงุฏ ุชุฑูƒูŠุฒู‡ ุจุงู„ุฏู… ุงุฐุง ุฎุฐุชู‡ ูˆูŠ fluconanzol ุงู„ู„ูŠ ูŠูƒูˆู† Inhibitor of CYP2C9

๐ŸŸกAcetaminophen :
โœ”๏ธู…ู‡ู… ุชุนุฑู ุงู†ูˆ ู‡ูˆ ูŠุซุจุท PG ุงู„ู„ูŠ ู…ูˆุฌูˆุฏ ุจ CNS
ู…ุงู„ู‡ ุนู„ุงู‚ุฉ ุจู€ Peripheral
ู„ุฐู„ูƒ ู‡ูˆ weak Anti-inflammatory ูˆู…ุง ูŠุนุชุจุฑูˆู‡ NSAIDS

โœ”๏ธุดุฎุต ุนู†ุฏู‡ ู…ุดุงูƒู„ ุจุงู„ู…ุนุฏุฉ ุฃูˆ ู…ุง ูŠุฑูŠุฏ ูŠุณุชุฎุฏู… NSAIDS ู†ู†ุทูŠ ู‡ุฐุง

โœ…"ูŠุนุชุจุฑ ุงู„ุฎูŠุงุฑ ุงู„ู…ูุถู„ ู„ู„ู…ุฑุถู‰ ุงู„ุนุฏู‡ู… ุนุฏูˆู‰ ููŠุฑูˆุณูŠุฉ ุจุชุณูƒูŠู† ุงู„ุฃู„ู… ูˆุฎูุถ ุงู„ุญุฑุงุฑุฉ"

๐Ÿค”ู‡ุฐุง Aceta ุฌุฒุก ู…ู†ู‡ ุจุงู„ู…ูŠุชุงุจูˆู„ุฒู… ูŠุชุญูˆู„ ุฅู„ู‰ NAPQI ู…ุงุฏุฉ ุณุงู…ุฉ ุชุฃุฐูŠ ุงู„ูƒุจุฏ
ุจุงู„ุญุงู„ุฉ ุงู„ุทุจูŠุนุฉ ุงู„ุฌุณู… ุนู†ุฏู‡ ุฌู„ูˆุชุงุซุงูŠูˆู† ูˆูŠุชุฎู„ุต ู…ู†ู‡ุง

๐Ÿค”ุจุงู„ุฌุฑุน ุงู„ุทุจูŠุนุฉ ู…ุงุจูŠ ู…ุดุงูƒู„
ุจุงู„ุฌุฑุน ุงู„ุนุงู„ูŠุฉ ุฑุงุญ ูŠุฎู„ุต ุฎุฒูŠู† ุฌู„ูˆุชุงุซุงูŠูˆู† ูˆูŠุณูˆูŠู„ูŠ Hepatic necrosis

๐Ÿค”ูˆุฎุงุตุฉ ุนู†ุฏ ุงู„ู†ุงุณ ุงู„ู„ูŠ ู‡ู…ู‡ :
hepatic disease,viral hepatitis,history of alcoholism
ุงู„ู„ูŠ ูŠุนุงู„ุฌู„ูŠ ุงู„ุณู…ูŠุฉ ู…ู‡ู… ุฌุฏุง
โœ…N-acetylcysteine

Traditional DMARDS
ู†ูุณ ุงู„ุฃุดูŠุงุก ุงู„ุฎุฐู†ุงู‡ู† ุจุงู„ูƒู„ู†ูƒู„
ู…ุฌุฑุฏ ูŠุชุดุฎุต RA ุงุจุฏูŠ ุจูŠู‡ู† ูˆุงู„ู…ูุถู„ MTX

MTX:
ู‡ูˆ Folic acid antagonist
ู…ู…ูƒู† ูŠุนุงู„ุฌู„ูŠ psoriasis arthritis

ุงู„ูุนุงู„ูŠุฉ ู…ุงู„ุชู‡ ุชุญุชุงุฌ ูฃ-ูฆ ุฃุณุงุจูŠุน
ูŠู†ูˆุฎุฐ ู…ุฑุฉ ุจุงู„ุฃุณุจูˆุน

โœจุฃู‡ู… ุฃุนุฑุงุถู‡ ูŠุณูˆูŠ cirrhosis of liver , pneumonia like syndrome
ุญุชู‰ ูŠู‚ู„ู„ูˆู† ุงุนุฑุงุถู‡ ู…ู…ูƒู† ูŠู†ุทูˆู† leucovorin ุจุนุฏ MTX
ูˆู…ู…ูƒู† F.A supplements

โš ๏ธู…ู…ู†ูˆุน ุงู†ุทูŠ ู„ู„ุญุงู…ู„

hydroxychoroquine:
early,mild RA ูŠุณุชุฎุฏู… ููŠ
ูุนุงู„ูŠุชู‡ ูŠู„ุง ุชุจุฏูŠ ูฆุงุณุงุจูŠุน - ูฆ ุงุดู‡ุฑ
ูŠุณูˆูŠู„ูŠ ู…ุดุงูƒู„ ุจุงู„ุนูŠู† ุฃู‡ู…ู‡ุง
โœจirreversible retinal damage, corneal deposit
โœจูˆูƒุฐู„ูƒ skin discoloration, eruption

leflunomide:
๐Ÿ“ŽูŠุฑุชุจุท ุจู€ DHODH ุงู†ุฒูŠู… ูŠุฏุฎู„ ุจุชุตู†ูŠุน Pyrimdine
ู…ู† ูŠุฑุชุจุท ุจู‡ุฐุง ุงู„ุฃู†ุฒูŠู… ุฑุงุญ ูŠุซุจุทู‡ ูู€ ุฑุงุญ ูŠู‚ู„ู„ ุงู„ุฃู„ู…
ุญุชู‰ ู…ุชู†ุณู‰ ุงุชุฐูƒุฑ ูŠู‡ูˆุฏุง
ูŠู†ูˆุฎุฐ ูˆุญุฏู‡ ุงูˆ ุจุญุงู„ุฉ ู…ุง ุงุชุญู…ู„ ุงู„ู…ุฑูŠุถ MTX
ูˆู…ู…ูƒู† ูŠู†ูˆุฎุฐ ุณูˆุฉ

โœจุงู‡ู… ุณุงูŠุฏ ุงููƒุช ู‡ูˆ Flue-like syndrome

โš ๏ธู…ู…ู†ูˆุน ุนู„ู‰ ุงู„ุญุงู…ู„

sulfasalazine:
๐Ÿ›‘ู…ุฏุฉ ูุนุงู„ูŠุชู‡ ุญุชู‰ ุชุจุฏูŠ ุชุญุชุงุฌ ูก-ูฃ ุงุดู‡ุฑ
ูŠุณูˆูŠู„ูŠ leoukpeina
ุณุงู„ุงุฒูŠู† = ุณุงู„ ุฏู…ู†ุง
Glucocorticoids:
๐ŸŸกูŠุณุชุฎุฏู… ูƒู€ ู…ุถุงุฏ ุงู„ุชู‡ุงุจ ุจู€ RA
ูˆุฌุณุฑ ู„ู„ู€ DMRDS ู„ุงู† ูŠุชุฃุฎุฑ ู…ูุนูˆู„ู‡ู†
ูŠุณุชุฎุฏู… ู„ูุชุฑุฉ ู‚ุตูŠุฑุฉ ูˆุจุฌุฑุน ู‚ุตูŠุฑุฉ

#DMARDs
ุฌุงุจุชุฑ adrenal
ู…ู†
ุงู„ุฃุดูŠุงุก ุงู„ู…ู‡ู…ู‡ ู‡ูŠ ูƒู„ zone ูˆ ุดู†ูˆ ุชูุฑุฒ :
โ€ขglomerulose โ€”> mineralocorticoid
โ€ขfasciculate โ€”> glucocorticoid
โ€ขreticularial โ€”> androgen

ู…ุนู„ูˆู…ุงุช ุนู† glucocorticoid :
ุงูˆู„ ุดูŠ ู‡ุฐุง ูŠุฒุฏุงุฏ ุฅูุฑุงุฒู‡ early morning ูˆ ูŠุจุฏุงู‹ ูŠู‚ู„ afternoon

ุซุงู†ูŠ ุดูŠ ู‡ุฐุง ูŠุญุณู† ู…ู† metabolism ู„ุงู†ู‡ ูŠุณูˆูŠ ุฒูŠุงุฏู‡ ุจ glucose ุจุงู„ุชุงู„ูŠ ูŠู‚ุงูˆู… stress ูˆ ุจุงู„ุชุงู„ูŠ ูŠุณูˆูŠ hyperglycaemia

ู…ู† ูŠูŠุฌูŠ ุจุงู„ุณุคุงู„ ูŠูƒูˆู„ :
glucocorticoid insufficiency results:
a-hypertension
B-hypotension
C-hyperglycaemia
D-hypoglycaemia


ู„ุงุฒู… ุชุนุฑููˆู† ุดู†ูˆ ูุฑู‚ ุจูŠู† primary and secondary and tertiary adrenocorticoid insufficiency :

Primary โ€”> ูŠุนู†ูŠ ุงู„ุฎู„ู„ ุจ ุงู„ุบุฏู‡ ู†ูุณู‡ ู…ุซู„ Addison disease

Secondary โ€”> ูŠุนู†ูŠ ุงู„ุฎู„ู„ ุจ ACTH

Tertiary โ€”> ูŠุนู†ูŠ ุงู„ุฎู„ู„ ุจ CTH

ู…ู„ุงุญุธู‡ :
- ุขู…ู† ูˆุงุญุฏ ู„ู„ุญุงู…ู„ prednisone
- ุงูƒุซุฑ ุงุนุฑุถ ุดุงุฆุนู‡ osteoporosis and hypokalemia
- ุฅุฐุง ู†ู‚ุทุน ุงู„ุนู„ุงุฌ ุจุตูˆุฑู‡ ู…ูุงุฌุฆู‡ ุฑุงุญ ูŠุตูŠุฑ ู†ู‚ุต ุญุงุฏ ุจ HPA
#adrenal
ู…ู† ุงู„ุจูˆุช @Muntadhar_21bot

- ู…ูˆุงุถูŠุน ุงู„ุงุณุชุฑูˆุฌูŠู† -

๐Ÿ”บ ุงุบู„ุจ ุงู„ุงุฏูˆูŠุฉ ุจู‡ุฐุง ุงู„ุฌุงุจุชุฑ ู‡ูŠ
agonist in bone โœ…
antagonists in breastโŒ
ุงูƒูˆ ุงุฏูˆูŠุฉ ู…ุณู…ูˆู…ุฉ ุชุณู… ุงู„ุฑุญู… (TS) ูุชุณูˆูŠ ุณุฑุทุงู† ุจุงู„ุฑุญู… ุงู„ูŠ ู‡ูŠ
Tamoxifen
Ospemifen

๐Ÿ”บ Raloxifen
ุฑุฌู„ ู„ุฐู„ูƒ ูŠููŠุฏ ู„ู„ู€ OP ู…ุนู†ุงู‡ุง Agonist in bone
๐Ÿ”บ Clomiphene
ูƒู„ ูŠูˆู… ุฌุงูŠุจุฉ ุงุซู†ูŠู†
ุงู„ุณุงูŠุฏ ุงููƒุช ู‡ูˆ Multiple birth (Twin)
ูู†ุณุชู†ุชุฌ ุงู†ูˆ ุตุงูŠุฑ Ovarian enlargement ุงู„ุณุจุจ ู‡ูˆ partial agonist in ovary
ูˆุงูŠุถุง ุตุงุฑ ุชุถุฎู… ุจุงู„ู…ุจุงูŠุถ ุจุณุณ ุฅูุฑุงุฒ ุนุงู„ูŠ ู„ู„ LH,FSH>>>>
ุงู„ุณุจุจ negative feedback
ุจุณุจุจ ุงู†ูˆ ุนู†ุฏู‡ Antagonists in hypothalamus
๐Ÿ”บ Ospemifen treat dyspareunia (painful in sexual intercourse)

โš•๏ธŽแš”แš”แš”แš”แš”แš”แš”แš”แš”แš”แš”แš”แš”แš”แš”โš•๏ธŽ
#ู‚ุฑุงุฆู† ูุงุฑู…ุง | Estrogen
โžฅ @muntedher_Alhussainy
#estrogen
ู…ู† ุงู„ุจูˆุช @Muntadhar_21bot

ุงู„ุณุงูŠุฏ ุงูŠููƒุช ุงู„ู…ุดู‡ูˆุฑุฉ ู„ุจุนุถ ุงุฏูˆูŠุฉ ุงู„ุงู†ุชูŠูƒุงู†ุณุฑ ุจุตูˆุฑุฉ
โš•๏ธŽแš”แš”แš”แš”แš”แš”แš”แš”แš”แš”แš”แš”แš”แš”แš”โš•๏ธŽ
#ู‚ุฑุงุฆู† ูุงุฑู…ุง | Anticancer
โžฅ @muntedher_Alhussainy
#cancer
ู…ู† ุงู„ุจูˆุช @Muntadhar_21bot

ู‚ุฑูŠู†ุฉ ู„ุฃุฏูˆูŠุฉ ุชูƒูˆู†
synthetic analogs of GnRH

- ูƒู„ู†ุง ู†ุนุฑู ุงู„ุนุงุจ ุงู„ู„ูŠฺฏูˆ ุŒ ู‡ูŠ ุงู„ุนุงุจ ุชุฑูƒูŠุจูŠุฉ ุชุชูƒูˆู† ู…ู† ู‚ุทุน ุŒ ูุฃูƒูˆ ู„ุนุจุฉ ู„ูŠฺฏูˆ ู…ูƒูˆู†ุฉ ู…ู† ุชู„ุซ ู‚ุทุน
Tri-le-go

Tri = triptorelin
le=leuprolide
go= goserelin
โš•๏ธŽแš”แš”แš”แš”แš”แš”แš”แš”แš”แš”แš”แš”แš”แš”แš”โš•๏ธŽ
#ู‚ุฑุงุฆู† ูุงุฑู…ุง | Anticancer
โžฅ @muntedher_Alhussainy
#cancer
๐Ÿ”บ ุงูˆู„ ุนุงุฆู„ุฉ Short acting (1-12h)

ู…ุชูƒูˆู†ุฉ ู…ู† ุดุฎุตูŠู†
Cortisone --- Oral
Hydrocortisone
ูŠุญุฌูˆุง ุจุงู„ุฎู„ุทุงุช ุงู„ูŠ ุชุณุชุฎุฏู… ู„ู„ูˆุฌู‡ ู„ุฐู„ูƒ ู‡ูˆ Topical

๐Ÿ”บุงู„ุนุงุฆู„ุฉ ุงู„ุซุงู†ูŠุฉ intermediate 12-36h

ุนุงุฆู„ุฉ ู…ู† ูค ู†ูุฑุงุช ุญุงู„ุชู‡ู… ุงู„ู…ุงุฏูŠุฉ ูˆุณุท
Predisone ุงู„ุงุจู†
Prednisolone ุงู„ุงุจ
Methylprednisolon ุงู„ุงู…
Triamcinolone ุงู„ุฒูˆุฌุฉ ุงู„ุซุงู†ูŠุฉ (ุงู„ุถุฑุฉ)
ุงู„ุงุจู† ุจุนุฏู‡ ุตุบูŠุฑ ูŠูƒุฏุฑ ูŠุงุฎุฐ Oral ูู‚ุท
ุงู„ุงุจ ุฑุฌุงู„ ุฌุจูŠุฑ ู…ูŠูƒุฏุฑ ูŠุจู„ุน ูˆุตุญุชู‡ ุชุนุจุงู†ุฉ ูุนุงูŠุด ุน ุงู„ุงุจุฑ IM & IV
ุงู„ุงู… (ู…ุซู„) ุชู‚ู„ุฏ ู‡ูˆุงูŠ ุชู‚ู„ุฏ ุถุฑุชู‡ุง ูˆุงู… ุถุฑุชู‡ุง๐Ÿ˜ ูˆู‡ุณู‡ ุงูƒูˆู„ูƒู… ู…ู†ูˆ ุถุฑุชู‡ุง ุงู„ู…ู‡ู… ู†ู†ุทูŠู‡ุง Topical + IA

Triamcinolone
T.. topical
IA.. Intraarticular
IM.. intramuscular
In. Inhaler
ุงู„ุถุฑุฉ ุงู„ุซุงู†ูŠุฉ ุงุฌุชูŠ ู…ู† ุนุงุฆู„ุฉ ุงู…ูˆุฑู‡ู… ุงู„ู…ุงุฏูŠุฉ ุนุงู„ูŠุฉ ุชุฒูˆุฌุช ุจุนุงุฆู„ุฉ ุงู…ูˆุฑู‡ู… ูˆุณุท ูŠุนู†ูŠ ุงุฎุฐุช ุตูุฉ ู…ู† ุงู‡ู„ู‡ุง ุงู„ูŠ ู‡ูŠ
No Mineralocorticoids

๐Ÿ”บุงู„ุนุงุฆู„ุฉ ุงู„ุซุงู„ุซุฉ long acting 36-55 h

ุฐูˆู„ูŠ ุงู…ูˆุฑู‡ู… ุงู„ู…ุงุฏูŠุฉ ูƒู„ุด ุนุงู„ูŠุฉ ู„ุฏุฑุฌุฉ ู…ุงุนุฏู‡ู… ฺฏุฏูˆุฑุฉ(ู…ุนุฏู†) ูŠุนู†ูŠ ุชุงุซูŠุฑู‡ู… ูู‚ุท ุณุชูŠุฑูˆูŠุฏ ุงู…ุง Mineralocorticoids ู…ุงุนุฏู‡ู…

Betamethasoneุงู„ุงุจ -- B ..toPical
Dexamethasoneุญุจูˆุจ ุฏูƒุณู†..ุงู„ุงู…(oral)
ุฐูˆู„ูŠ ุงู„ุงุซู†ูŠู† ุงู†ุทูŠู†ุงู‡ู… ุณุงุจู‚ุง ู„ู„ุญุงู…ู„ ุงุจุฑุฉ ุงูƒุชู…ุงู„ ุงู„ุฑุฆุฉ ูู…ู†ู†ุณู‰ ุฐูˆู„ูŠ IV, IM

#adrenal
๐Ÿ”–ู…ุฑุงุฌุนุฉ ุณุฑูŠุนุฉ ู„ู„ูƒุฌุฑ 4

๐Ÿ’€Drugs affecting bone metabolism

๐Ÿค”ุดู†ูˆ ู‡ูˆ paget disease โ“

๐Ÿ‘‰Is a disorder of bone remodeling that results in disorganization bone formation and enlarged or misshapen bones

๐ŸงุฒูŠู† ูŠุนู†ูŠ ูŠุดุจู‡ ู‡ุดุงุดุฉ ุงู„ุนุธุงู… ุŸ

ู„ุง ู„ุง ๐Ÿค“
๐Ÿ‘‰Paget disease limited to one or a few bones

๐Ÿค”ุดู†ูˆ ูŠุนู†ูŠ Osteomalasia ุŸ

๐Ÿ‘‰Is softening of the bones that is most often attributed to vitamin D deficiency


๐Ÿค”ุดู†ูˆ ู‡ูŠ ุงู„ Osteoclast ุŸ

๐Ÿ‘‰Are cells that break down bone , a process known as bone resorption

๐Ÿค”ูˆุดู†ูˆ ู‡ูŠ ุงู„ Osteoblast ุŸ

๐Ÿค”Called bone building cells synthesis new bone

๐Ÿค”ุฒูŠู† ุดูˆูƒุช ูŠุตูŠุฑ ุงู„ bone loss ุŸ

๐Ÿค”When bone resorption exceeds bone formation during the remodeling process
๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”
Prevention of Osteoprosis


๐Ÿ’ฌุดูˆู† ู†ู‚ู„ู„ ุงู„ bone loss ุจุงู„ postmenopausal women โ€ผ๏ธ

๐Ÿ‘‰Adequate intake of Ca , Vit D
๐Ÿ‘‰Weight bearing exercise
๐Ÿ‘‰Smoking cessation
๐Ÿ‘‰Avoidance of alcohol intake
๐Ÿ‘‰Avoidance of glucocorticoids

๐Ÿ’กูˆู†ู†ุชุจู‡ ู‡ู†ุง ุงู† ุญุชู‰ ุงูŠ ุดุฎุต ุนู†ุฏู‡ ุฎุทุฑ ุงู„ุงุตุงุจุฉ ุจู‡ุดุงุดุฉ ุงู„ุนุธุงู… ู„ุงุฒู… ูŠุชุฌู†ุจ ุงู„ูƒูˆุฑุชุฒูˆู† โ€ผ๏ธ

ู„ุงู† ู…ุซู„ุง ุงุณุชุฎุฏุงู… ๐Ÿ‘‡
Prednisone 5 mg / d for 3 months or more
ู…ู…ูƒู† ูŠุฒูŠุฏ ู…ู† ุฎุทุฑ ุงู„ุงุตุงุจุฉ ุจู‡ุดุงุดุฉ ุงู„ุนุธุงู… ๐Ÿ’€

๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”
Treamtment of Osteoporosis


ุงู„ุนู„ุงุฌ ูŠูƒูˆู† ู„ุงูŠ ู…ุฑุถู‰ ุŸ
๐Ÿ‘‰Postmenopausal women
๐Ÿ‘‰Men > 50 years old
๐Ÿ‘‰Pt previous osteoporotic fracture
๐Ÿ‘‰Bone mineral density 2.5 standard deviation or more below
๐Ÿ‘‰Osteopenia with high probability of future fracture

#Dr_Cube_Pharmacy ๐Ÿฆท
#bone
๐Ÿ”– ูƒู„ ุงู„ุงุฏูˆูŠุฉ ุงู„ู…ุฐูƒูˆุฑุฉ ุจู„ูƒุฌุฑ 4

โžก๏ธDrugs affecting bone metabolism


โžก๏ธCalcium supplement

๐Ÿ’ŠCalcium carbonate โžก๏ธ 40% elemental calcium
ูˆูŠุคุฎุฐ ู…ุน ุงู„ูˆุฌุจุฉ

๐Ÿ’ŠCalcium citrate โžก๏ธ 21% elemental calcium
ูˆู…ู…ูƒู† ู†ุงุฎุฐู‡ ู‚ุจู„ ุงูˆ ุจุนุฏ ุงู„ุงูƒู„

๐Ÿ’ŠVitamin D2 ( ergocalciferol )
๐Ÿ’ŠVitamin D3 ( Cholecalciferol)


โžก๏ธBisphosphonate

๐Ÿ’ŠAlendronate
๐Ÿ’ŠRisedronate
๐Ÿ’ŠZoledronic acid
๐Ÿ’ŠEtidronate
๐Ÿ’ŠIbandronate
๐Ÿ’ŠPamidronate
๐Ÿ’ŠTiludronate


โžก๏ธMonoclonal antibody

๐Ÿ’ŠDenosumab


โžก๏ธParathyroid agents

๐Ÿ’ŠTeriparatide โžก๏ธ recombinant parathyroid hormone

๐Ÿ’ŠAbaloparatide โžก๏ธanalog of parathyroid hormone related peptide


โžก๏ธSelective estrogen receptor modulators

๐Ÿ’ŠRaloxifen


โžก๏ธCalcitonin



#bone
#๏ธโƒฃ ุฃู‡ู… ู…ุง ุจฺ†ุงุจุชุฑ 3๏ธโƒฃ ุชฺฏุฏุฑ ุชุนุชู…ุฏู‡ ูˆุชุนุชุจุฑู‡ ู…ุฑุงุฌุนุฉ ู„ู‚ุฑุงูŠุชูƒ
๐Ÿ”ก๐Ÿ” ๐Ÿ” ๐Ÿ” 1๏ธโƒฃ

Biologic DMARDs:
ุจูŠ ู†ูˆุนูŠู†
๐Ÿ˜€.Biologic TNF-ฮฑ
ู…ุฌู…ูˆุนุฉ ุจูƒู„ู…ุฉ ุณูŠุงุฌูŠ
Certolizumab,etanercept,adlimumab,Golimumab, Infliximab

๐Ÿ˜€.Non biolgic TNF-ฮฑ
ู…ุฌู…ูˆุนุฉ ุจูƒู„ู…ุฉ ART
Abatacept, Rituximab, Tocilizumab

๐ŸŸกุงู„ูุนุงู„ูŠุฉ ุชุณุชุบุฑู‚ ุฃุณุจูˆุนูŠู† ูŠู„ุง ุชุจุฏูŠ
๐ŸŸกุฃุณุชุฎุฏู…ู‡ู… ุจุญุฐุฑ ูˆูŠ ู…ุฑุถู‰ ูุดู„ ุงู„ู‚ู„ุจ
๐ŸŸกู…ู…ูƒู† ูŠุฒูŠุฏูˆู† ู…ุฎุงุทุฑ ุงู„ูƒุงู†ุณุฑ
๐ŸŸกูŠุณุชุฎุฏู…ูˆู‡ู… ุจุนุฏ ูุดู„ Traditional DMARDS
๐ŸŸ ู…ู…ูƒู† ูŠุณูˆูˆู† ุชู†ุดูŠุท ู„ู€ hepatitis B
ูˆูŠุฒูŠุฏู† ู…ุฎุงุทุฑ ุงู„ู€ infections ู…ุซู„ุง ูŠุณูˆู† TB
๐Ÿ›‘ู…ู…ู†ูˆุน ุฃู†ุทูŠ TNF-ฮฑ ูˆ non TNF-ฮฑ
๐Ÿ›‘ู…ู…ู†ูˆุน ุฃู†ุทูŠู‡ู… ูˆูŠ live vaccine
Adalimumab
ู…ุซู„ ู…ุง ุฐูƒุฑุช ุจุงู„ุจูˆุณุช ุงู„ู‚ุจู„ู‡ ู‡ูˆ
recombinant Monoclonal Antibody

๐Ÿ’กุงู„ู…ูŠูƒุงู†ุฒู… ู‡ูˆ ู†ูุณู‡ ุฑุงุญ ูŠู†ุนุงุฏ ุจุฃุบู„ุจ ุงู„ุฃุฏูˆูŠุฉ ูŠุฑุชุจุท ุจู€ TNF-ฮฑ ูˆูŠู…ู†ุนู‡ ู…ู† ุงู„ุฅุฑุชุจุงุท ุจุฑุณุจุชุฑ ุงู„ุฎู„ูŠุฉ ุจุงู„ุชุงู„ูŠ ู…ุงูƒูˆ ุงุณุชุฌุงุจุฉ ู…ู†ุงุนูŠุฉ ุจุงู„ุชุงู„ูŠ ู‚ู„ ุงู„ุฅู„ุชู‡ุงุจ ูˆุบูŠุฑู‡

๐Ÿ”˜ูŠู†ูˆุฎุฐ SC ูƒู„ ุฃุณุจูˆุน ุฃูˆ ูƒู„ ุฃุณุจูˆุนูŠู†
๐Ÿ”˜ูˆุงู‡ู… A.E: ุœ Agranulocytosis
Certolizumab
๐Ÿ’กู†ูุณ ุงู„ู…ูŠูƒุงู†ุฒู…
ูŠุฏู…ุฌูˆู‡ ูˆูŠ polyethylene glycol ุจุนู…ู„ูŠุฉ peglation "ุนู„ู…ูˆุฏ ูŠุฒูŠุฏูˆู† bioavailability ูˆ half-life ู„ู„ูู‡ู…"

๐Ÿ”˜ ูŠู†ูˆุฎุฐ SC ูƒู„ ุฃุณุจูˆุนูŠู†
Etanercept
ู‡ูˆ
genetically engineered fusion protein
ู…ู‡ู… ุชุนุฑูู‡ ูŠุฌูŠุจู„ูƒ ู‡ุงู„ุดูŠ ูˆูŠูƒู„ูƒ ู…ู†ูˆ ุงู„ุฃุฏูˆูŠุฉ ุนู†ุฏู‡ ู‡ุงู„ู…ูŠุฒุฉ ุชุฎุชุงุฑู‡

๐Ÿ’กุงู„ู…ูŠูƒุงู†ุฒู… ู†ูุณู‡
๐Ÿ”˜ ูŠู†ูˆุฎุฐ SC ูƒู„ ุฃุณุจูˆุน
Golimumab
๐Ÿ’ก ู†ูุณ ุงู„ู…ูŠูƒุงู†ุฒู…

๐Ÿ”˜ ูŠู†ูˆุฎุฐ SC ูƒู„ ุดู‡ุฑ ู…ุน Methotrexate
๐Ÿ”˜ู…ู…ูƒู† ูŠุฒูŠุฏ ุงู†ุฒูŠู…ุงุช ุงู„ูƒุจุฏ
Infliximab
ู‡ูˆ
Chimeric Monoclonal Antibody
ู…ู‡ู… ูŠุฌูŠุจ ู‡ุงู„ุดูŠ ูˆูŠุฑูŠุฏ ุงู„ุฅุณู… ูˆุดุฑุญุชู‡ ุจุงู„ุจูˆุณุช ุดู„ูˆู† ุตุงุฑ

๐Ÿ’กู†ูุณ ุงู„ู…ูŠูƒุงู†ุฒู…
โš ๏ธ ู…ุง ูŠู†ุทูŠ ูˆุญุฏู‡ ู„ุฃู† ูŠุตูŠุฑู„ู‡ anti-infliximab Antibody ู„ุฐู„ูƒ ูŠู†ุทูˆู† ูˆูŠุงู‡ Methotrexate
๐Ÿ”˜ูŠู†ูˆุฎุฐ IV Infusion ูƒู„ ูจ ุฃุณุงุจูŠุน "ุดู‡ุฑูŠู†"
Abatacept
๐Ÿ’กุงู„ู…ูŠูƒุงู†ุฒู… ูŠุชู†ุงูุณ ู…ุน CD28 ุนู„ู‰ ุงู„ุฅุฑุชุจุงุท ุจุงู„ุฑุณุจุชุฑุงุช ุงู„ู…ูˆุฌูˆุฏุฉ ุนู„ู‰ ุณุทุญ Macrophage ูˆ B cells

ุจุงู„ุชุงู„ูŠ ุฑุงุญ ูŠู…ู†ุน T cell ูŠุตูŠุฑู„ู‡ุง ุงุฑุชุจุงุท ุจุงู„ุฑุณุจุชุฑ ูŠุนู†ูŠ ู…ุง ุฑุงุญ ุชุชุญูุฒ ูุฑุงุญ ูŠู‚ู„ู„ ู…ู† ุงู„ุฅู„ุชู‡ุงุจ

๐Ÿ”˜ ูŠู†ูˆุฎุฐ IV Infusion ูƒู„ ูค ุฃุณุงุจูŠุน
๐Ÿ”˜ุฃู‡ู… upper respiratory infection: A.E
Rituximab
ู‡ูˆ ุฃูŠุถู‹ุง ูŠูƒูˆู†
Chimeric murine/human Monoclonal Antibody
ู…ู‡ู…ู…ู…ู…ู…

๐Ÿ’กุงู„ู…ูŠูƒุงู†ุฒู… ูŠุฑุชุจุท ุจู€ CD20 ุงู„ู…ูˆุฌูˆุฏ ุนู„ู‰ ุณุทุญ B cells
ุจุงู„ุชุงู„ูŠ ูŠู‚ู„ู„ ุฎุฑูˆุฌ B cell

๐Ÿ”˜ูŠู†ูˆุฎุฐ IV Infusion ูƒู„ ูกูฆ-ูขูค ุฃุณุจูˆุน
๐Ÿ”˜ู…ู…ูƒู† ูŠุณูˆูŠ ุญุณุงุณูŠุฉ ููŠู†ุทูˆู† ูƒูˆุฑุชูŠุฒูˆู†ุŒ ุจุฑุงุณูŠุชูˆู„ุŒู…ุถุงุฏ ู‡ุณุชุงู…ูŠู† ู‚ุจู„ ูƒู„ ุฌุฑุนุฉ
ูˆุฃู‡ู… A.E: ูŠุณูˆูŠ hypotension ูˆุฎุงุตุฉ ุนู†ุฏ ุฃูˆู„ ุฃุณุชุฎุฏุงู…
Tocilizumab & Sarilumab

๐Ÿ’ก ุงู„ู…ูŠูƒุงู†ุฒู… ูŠุฑุชุจุทูˆู† ุจุงู„ุฑุณุจุชุฑ ู…ุงู„ IL-6 ุจุงู„ุชุงู„ูŠ ูŠู…ู†ุนูˆู† ุฎุฑูˆุฌ IL-6 ุจุงู„ุชุงู„ูŠ ูŠู‚ู„ ุงู„ุฅู„ุชู‡ุงุจ

ู…ู‡ู… ุงุชุฐูƒุฑ ุฐูˆู„ ุงู„ุซู†ูŠู† ุฃุณู…ุงุฆู‡ู… ุจูŠู‡ุง il ูŠุนู†ูŠ ูŠุดุชุบู„ูˆู† ุนู„ู‰ IL
ูˆุงูˆู„ ุญุฑููŠู† ู…ู† ุฃุณู…ุงุฆู‡ู… ุชู†ุทูŠ ูƒู„ู…ุฉ ุณุช ูŠุนู†ูŠ 6
ููŠุดุชุบู„ูˆู† ุนู„ู‰ IL-6


๐Ÿ”˜ูŠู†ูˆุฎุฐู† ุซู†ูŠู†ู‡ู… SC ูƒู„ ุฃุณุจูˆุนูŠู†
ูˆู…ุฑุงุช Tocilizumab ูŠู†ูˆุฎุฐ IV ูƒู„ ูค ุฃุณุงุจูŠุน
๐Ÿ”˜ุฃู‡ู… A.E: ูŠุณูˆูˆู† hyperlipidemia , Hypertension
Tofacitinib
๐Ÿ’กู‡ูˆ Janus-Kinase Inhibitors
ูŠุณุชุฎุฏู… ู„ุนู„ุงุฌ moderate-severe RA
ู„ู„ู…ุฑูŠุถ ุงู„ู„ูŠ ู…ุง ุชุญุณู‘ู† ุฃูˆ ู…ุง ุฃุชุญู…ู„ MTX

๐Ÿ“Œุญุชู‰ ุฃุณุชุฎุฏู…ู‡ ู„ุงุฒู… HB ุฃูƒุซุฑ ู…ู† 9g/dl
ู„ุฃู† ู…ู…ูƒู† ูŠุณูˆูŠ anemia ู„ุฐู„ูƒ ู„ุงุฒู… ุฃุฑุงู‚ุจ ุงู„ู€HB

โœ”๏ธ ูŠููุถู„ ุฃุฎู„ูŠ ุขุฎุฑ ุฃุฎุชูŠุงุฑ ู„ุฃู† ู…ู…ูƒู† ูŠุณูˆูŠู„ูŠ malignancy ูˆุฎุงุตุฉ ุงุฐุง ุงู„ู…ุฑูŠุถ ู…ุง ุงุณุชูุงุฏ ุงูˆ ู…ุง ุงุชุญู…ู„ ุจู‚ูŠุฉ ุงู„ุฃุฏูˆูŠุฉ
๏ปฟ
โฌ‡๏ธTreatment of Gout โฌ‡๏ธ

๐ŸŸกู‡ุฏููŠ ู…ู† ุงู„ุนู„ุงุฌ ุฃู†ุฒู„ ุงู„ู€ uric acid ุงู‚ู„ ู…ู†
<6mg/dl
ูˆุงู„ุนู„ุงุฌ ุฃู…ุง ุฃูˆู‚ู ุชุตู†ูŠุน ุฃูˆ ุฃุฒูŠุฏ ุทุฑุญ U.A

ุจุนู„ุงุฌ ุงู„ู†ูˆุจุงุช Acut gout ู‡ู†ุฉ ุชู„ุงุซุฉ CNC
Corticosteroid, NSAIDS, Colchicine

ูˆุชุฌูŠ ุงู„ู†ูˆุจุฉ ู„ุนุฏุฉ ุฃุณุจุงุจ ู…ู†ู‡ุง
๐Ÿ”ข. ูŠุดุฑุจ ูƒุญูˆู„ ู‡ูˆุงูŠ
๐Ÿ”ข. ูŠุงูƒู„ ูƒู…ูŠุงุช ูƒุจูŠุฑุฉ ู…ู† purine
๐Ÿ”ข. ู…ุฑุถ ูƒู„ูˆูŠ

ูˆู…ู…ูƒู† ูŠู†ุทูˆู† ุนู„ุงุฌ ูˆู‚ุงุฆูŠ ุญุชู‰ ู…ูŠุตูŠุฑ ุนู†ุฏูŠ ู†ูˆุจุฉ ูˆุฎุงุตุฉ ุงุฐุง ูƒุงู† ุนู†ุฏูŠ ุฃูƒุซุฑ ู…ู† ู†ูˆุจุชูŠู† ุจุงู„ุณู†ุฉ ุงูˆ ู…ุฑุถ ูƒู„ูˆูŠ ุงูˆ ุญุตูˆู‰ ุจุงู„ูƒู„ู‰ ุงูˆ tophi

๐Ÿ””ู‡ุณุฉ ู†ุณูˆู„ู ุจุงู„ุนู„ุงุฌ ูˆุฎุงุตุฉ Chronic Gout
ู‡ู†ุฉ ฺฏุฑูˆุจูŠู† ุฃู…ุง ุฃุฒูŠุฏ ุงู„ุทุฑุญ ุฃูˆ ุงู‚ู„ู„ ุงู„ุฅู†ุชุงุฌ ู…ุงู„ uric acid
๐Ÿ˜€.xanthaine oxidase Inhibitor ( allopurinol, febuxostat)
First line urate lowering agent

๐Ÿ˜„.Uricosuric agent (Probencid)
ู‡ุงูŠ ุชุฒูŠุฏ ุงู„ุทุฑุญ ู…ุงู„ u.a ูˆุชููŠุฏ ููŠ ุญุงู„ุฉ ุงู„ู…ุฑูŠุถ ู…ุง ุงุณุชุฌุงุจ ู„ู„ู€ ุงู„ฺฏุฑูˆุจ ุงู„ุฃูˆู„ ุฃูˆ ู…ุง ุงุชุญู…ู„ู‡ู…

๐Ÿ”– ูˆุงูˆู„ ู…ุง ุฃุจุฏูŠ ุฃุณุชุฎุฏุงู… ูˆุงุญุฏ ู…ู† ุฐู† ู„ุงุฒู… ุงู†ุทูŠ ูˆูŠุงู‡ู… Anti-inflammatory ุญุชู‰ ุงู…ู†ุน Acut gout ูˆูŠุณุชู…ุฑ ุนู„ูŠู‡ ุงู‚ู„ ุดูŠ ูฆ ุฃุดู‡ุฑ
Colchicine
ู‡ูˆ ู„ุง ู…ุณูƒู† ูˆู„ุง uricosuric ู‡ูˆ ู…ุฌุฑุฏ ูŠุฎูู ุงู„ุฃู„ู… ุงู„ู„ูŠ ูŠุตูŠุฑ ูˆูŠ Acute gout

๐Ÿ’กูŠุฑุชุจุท ุจุงู„ู€ tubulin,microtubulin ูˆูŠุณูˆูŠ depolymerization
ูˆูŠุฎุฑุจุท ุดุบู„ ุงู„ุฎู„ูŠุฉ ููŠู…ู†ุน neutrophils ุชุฑูˆุญ ู„ู„ู…ูุตู„ ุงู„ู…ุตุงุจ ูˆุชุณูˆูŠู„ูŠ ุงู„ุชู‡ุงุจ
ูˆูƒุฐู„ูƒ ูŠู…ู†ุน ุฃู†ู‚ุณุงู… ุงู„ุฎู„ูŠุฉ ู„ุฃู† ูŠุฑุชุจุท ุจู€ mitotic spindle

โœ”๏ธ ูŠุฎูู ุงู„ุฃู„ู… ุฎู„ุงู„ ูกูขุณ ู…ู† ุงู„ุฅุตุงุจุฉ
โœ…ู…ุง ูŠุตูŠุฑ ู†ู†ุทูŠ ุจุนุฏ ูฃูฆุณ ู…ู† ุงู„ุฅุตุงุจุฉ
๐Ÿ“ŒูŠุตูŠุฑู„ู‡ metabolism ุนู† ุทุฑูŠู‚ CYP3A4
๐Ÿ”˜ุฃู‡ู… A.E : ุœmyopathy, aplastic anemia

โš ๏ธู…ู…ู†ูˆุน ุฃู†ุทูŠ ู„ู„ุญุงู…ู„
โšก๏ธุฃุนุฏู„ ุงู„ุฌุฑุนุฉ ุงุฐุง ุฃุฎุฐู‡ ูˆูŠ CYP3A4 Inhibitors ุฃูˆ p-glycoprotein
ุฃูˆ ู…ุฑุถู‰ ุงู„ูƒู„ู‰
ูŠุชุจุน.....#DMARDs
๐Ÿ” ๐Ÿ” ๐Ÿ” ๐Ÿ” 2๏ธโƒฃ

Allopurinol
๐Ÿ’กูŠุฑุชุจุท ุจู€ oxidase enzyme ููŠู…ู†ุน ุขุฎุฑ ุฎุทูˆุชูŠู† ู…ู† ุชูƒูˆู† Uric acid

๐Ÿ˜ูุนุงู„ ุจุนู„ุงุฌ gout , ูˆ hyperuricemia ุงู„ู„ูŠ ุชุฌูŠ ู†ุชูŠุฌุฉ malignancy ุงูˆ Renal disease

โœ”๏ธูŠุชุญูˆู„ ุงู„ู‰ metabolite ูŠุณู…ูˆู‡ alloxanthine (oxypurinol)
ูˆ ุงู„ู€ half-life ู…ุงู„ุชู‡ู… ู…ู† ูกูฅ-ูกูจ ุณุงุนุฉ
ูŠู†ูˆุฎุฐ ู…ุฑุฉ ุจุงู„ูŠูˆู…
โœ…ุฃุนุฏู„ ุงู„ุฌุฑุน ููŠ ุญุงู„ุฉ ูƒุงู† GFR ุฃู‚ู„ ู…ู† 30
๐Ÿ”˜ุฃู‡ู… A.E : ุœskin rash
Febuxostat
ู†ูุณ ุฃุฎูˆู‡ ูŠู†ูˆุฎุฐ ุงูˆุฑู„ ุจุณ ุงู„ุญุณุงุณูŠุฉ ุจุงู„ุฌู„ุฏ ุฃู‚ู„

โš ๏ธุฃุณุชุฎุฏู…ู‡ ุจุญุฐุฑ ูˆูŠ ู…ุฑุถู‰ ุงู„ู‚ู„ุจ
ู„ุฃู† ูŠุณูˆูŠ ู…ุดุงูƒู„ ุจุงู„ู‚ู„ุจ ุนูƒุณ ุฃุฎูˆู‡ ุงู„ููˆฺฏ allopurinol
Probencid
oral uricosuric acid
๐Ÿ’กูŠุฒูŠุฏ ุทุฑุญ uric acid ู…ู† ุฎู„ุงู„ ุชุซุจูŠุท
urate - anion exchange in proximal tubule

โš ๏ธู…ู…ู†ูˆุน ุฃุณุชุฎุฏู…ู‡ ุฅุฐุง creatinine clearance ุฃู‚ู„ ู…ู† 50ml/min
๐Ÿ”˜ุฃู‡ู… A.E : ุœdermatologic reaction
Pegloticase
ู‡ูˆ ู…ุตู†ุน ูˆู…ุดุงุจู‡ ู„ุฃู†ุฒูŠู… ุฅุณู…ู‡ urate oxidase ุงูˆ uricase
ู…ู† ุฅุณู…ู‡ ุชุนุฑู ุฅุณู… ุงู„ุฃู†ุฒูŠู…

ูŠุญูˆู„ ุงู„ูŠูˆุฑูƒ ุงู„ู‰ allntoin ู…ุงุฏุฉ ุชุฐูˆุจ ุจุงู„ู…ูŠ ูˆุชุทู„ุน ุจุงู„ูƒู„ู‰

โœ”๏ธูŠุณุชุฎุฏู… ููŠ ุญุงู„ ุนุฏู… ุงู„ุงุณุชุฌุงุจุฉ ู„ุฃุฏูˆูŠุฉ first line
๐Ÿ”˜ูŠู†ูˆุฎุฐ IV Infusion ูƒู„ ุฃุณุจูˆุนูŠู†
๐Ÿ”˜ู…ู…ูƒู† ูŠุณูˆูŠ ุญุณุงุณูŠุฉ ููŠู†ุทูˆู† ู…ุถุงุฏ ู‡ุณุชุงู…ูŠู† ูˆ ูƒูˆุฑุชูŠุฒูˆู† ู‚ุจู„ ู…ุง ูŠุณุชุฎุฏู…ูˆู‡
๏ปฟ
#DMARDs
๐Ÿ“ŒูŠู‚ูˆู„ูƒ ู…ู†ูˆ ุฃู‚ูˆู‰ corticosteroids ู…ู† ู†ุงุญูŠู‡ Anti inflammation effect?? ูˆูŠูƒูˆู†ู† long acting?

1.. Betamethasone
2..Dexamethasone


๐Ÿ“Œู…ู†ูˆ ุฃู‚ูˆู‰ corticosteroids ู…ู† ู†ุงุญูŠู‡ amineralocortiocids ูŠุนู†ูŠ salt and water retaining effect??

Fluudrocortison

ุฃูƒุซุฑ ุดูŠ ู…ู‡ู…ุงุช ู‡ุฐู†ูŠ

ุงู„ุจุงู‚ูŠ ุงุทู„ุนูˆุง ุนู„ูŠู‡ู… ู…ู†ูˆ ุดูˆุฑุช ูˆู…ู†ูˆ ุงู†ุชูŠุฑู…ูŠุฏูŠุช

ูˆุงู„ ูˆู‚ุช

Short 1_12 hours

Intermediate 12_36 hours

Long 36_55 hou

#Adrenal glands ๐Ÿ’ฅ๐Ÿ’ฅ
Adverse effects of Long term corticosteroid therapy :
1๏ธโƒฃ Osteoporosis
ุจู‡ู„ ุญุงู„ุฉ ู…ู…ูƒู† ุงู†ุทูŠ Bisphosphonates

2๏ธโƒฃ Cushing-like syndrome

3๏ธโƒฃ Cataracts

4๏ธโƒฃ Hyperglycemiaโžก๏ธDM

5๏ธโƒฃ Topical therapy can cause skin atrophy, ecchymosis, and purple striae.

6๏ธโƒฃ Decrease growth in children

7๏ธโƒฃ glaucoma

8๏ธโƒฃ centripetal distribution of body fat

9๏ธโƒฃ increase risk of infection

๐Ÿ”Ÿ emotional disturbances

1๏ธโƒฃ1๏ธโƒฃ hypokalemia

1๏ธโƒฃ2๏ธโƒฃ hypertension

1๏ธโƒฃ3๏ธโƒฃ peripheral edema.


#adrenal chapter
ุตุงุจุฑูŠู†ุง ุŒ ูˆูƒูˆุฑุชูŠูƒูˆ
Spironolactone:
ุตุงุจุฑูŠู†ุง ุชุทุฑุฏ ุงู„ุตูˆุฏูŠูˆู… ูˆุชุญุชูุธ ุจุงู„ุจูˆุชุงุณูŠูˆู…
ูˆุจุงู„ุชุงู„ูŠ ุญุชุณุจุจ hyperkalemia

Corticosteroid:
ุนู…ู†ุง ูƒูˆุฑุชูŠูƒูˆ ูŠุญุชูุธ ุจุงู„ุตูˆุฏูŠูˆู… (ู„ู‡ุฐุง ูŠุณุจุจ ุถุบุท ูˆุงุญุชุจุงุณ)
ูˆูŠุทุฑุฏ ุงู„ุจูˆุชุงุณูŠูˆู… ูˆุญูŠุณุจุจ
Hypokalemia
ู…ุฎุชุตุฑ :
ูƒูˆุฑุชูŠูƒูˆ = ูŠูƒุฑู‡ ุงู„ุจูˆุชุงุณูŠูˆู…=hypokalemia
ุจูŠู†ู…ุง ุตุงุจุฑูŠู†ุง ุตุงุจุฑู‡ ุนู„ู‰ ุงู„ุจูˆุชุงุณูŠูˆู… ูˆุชุญุชูุธ
ุจูŠ ูู€ ุชุณุจุจ hyperkalemia

#Adrenal chapter
โญ•๏ธุœ
ุฃุฏูˆูŠุฉ RA ูˆุดฺฏุฏ ู†ุณุชุฎุฏู…ู‡ู… ู…ู‡ู…ุงุงุงุงุงุช ุฌุฏู‹ุง

Adalimumab โžก๏ธ weekly
or every other week

Certolizumab โžก๏ธ every 2 w

Etanercept โžก๏ธ once weekly

Golimumab โžก๏ธ once a month

Infliximab โžก๏ธ every 8 w

Abatacept โžก๏ธ every 4 w

Rituximab โžก๏ธ every 16โ€“24 w

Tocilizumab โžก๏ธ every 2 w
also IV every 4 w

Sarilumab โžก๏ธ every 2 w

#DMARDs
โค1
โญ•๏ธุœ
ุฃุฏูˆูŠุฉ bisphosphonates ู„ุนู„ุงุฌ OP ูˆุฃู‡ู… ุงู„ู…ู„ุงุญุธุงุช ุนู„ูŠู‡ุง

"Alendronate"
if oral tab โฉ daily or weekly
if effervescent โฉ weekly

"Ibandronate"
if oral tab โฉ daily or monthly
if intravenous โฉ every 3 month

"Risedronate"
if oral tab โฉ daily,weekly, or monthly
if oral delayed-release tab โฉ weekly

"Zoledronic acid"
intravenous โฉ yearly

โšก๏ธ ูƒู„ู‡ู… ู„ุงุฒู… ุฃุฎุฐู‡ู… ูˆูŠ ู…ุงุก ุทุจูŠุนูŠ ู„ุง ุญู„ูŠุจ ูˆู„ุง ูƒู‡ูˆุฉ ูˆู„ุง ุนุตูŠุฑ ..
โบ๏ธู„ุงุฒู… ูŠูƒูˆู† ุงู„ู…ุงุก ุญูˆุงู„ูŠ ูฆ-ูจ ุงูˆู†ุต ูŠุนู†ูŠ ุจุญุฏูˆุฏ ูกูฆู -ูกูจู  ู…ู„
โบ๏ธูŠู†ูˆุฎุฐูˆู† ู‚ุจู„ ุงู„ุฃูƒู„ ูˆุงู„ุฃุฏูˆูŠุฉ ุจู†ุต ุณุงุนุฉ (ุนุฏุง Ibandronate ุจุณุงุนุฉ)
โบ๏ธูŠุญุชุงุฌ ุชูƒุนุฏ ุงูˆ ุชูˆูƒู ู…ุฏุฉ ู†ุต ุณุงุนุฉ ู„ูƒู„ ุงู„ุฃุฏูˆูŠุฉ(ุนุฏุง Ibandronate ูŠุญุชุงุฌ ุณุงุนุฉ)

โœจุฅุณุชุซู†ุงุก ุจุณูŠุท ูู‚ุท
Risedronate delayed release tab
๐Ÿ”ขูŠุญุชุงุฌ ุฃู‚ู„ ุดูŠ ูค ุงูˆู†ุต ู…ู† ุงู„ู…ุงุก ูŠุนู†ูŠ ูจู ู…ู„ ุชู‚ุฑูŠุจุง
๐Ÿ”ขูˆูŠู†ูˆุฎุฐ ุจุนุฏ ูˆุฌุจุฉ ุงู„ูุทูˆุฑ ู…ุจุงุดุฑุฉ
#DMARDs
ูˆุจูŠู†ู…ุง ุฃู†ุง ุฃุทู„ุจ ู…ุดูŠุฆุชูƒุŒ ู‚ู„ุจูŠ ูŠุชู…ู†ู‰ ุฃู† ุชุชูู‚ ู…ุดูŠุฆุชูƒ ู…ุน ู…ุดูŠุฆูŽุชูŠ ู‡ุฐู‡ ุงู„ู…ูŽุฑุฉ ูŠุง ุงู„ู„ู‡.๐Ÿ’ž
-
Please open Telegram to view this post
VIEW IN TELEGRAM
โค4
Raloxifene agonist โžก๏ธ bone
Raloxifene antagonist โžก๏ธbreast +endometrium


Tamoxifen agonist โžก๏ธ bone + endometrium.
Tamoxifen antagonist โžก๏ธ breast

#pharmacology

*#Estrogen chapter
ุงู„ side effects ุงู„ู…ู…ูŠุฒุฉ ู…ู† NSAID ุฅู„ู‰ Diabetes


Salicylism (mild toxicity of salicylate ) โ†’mental confusion , dizziness,
tinnitus, hyperventilation confusion ,



Severe toxicity of salicylate โ†’ Restlessness, delirium, hallucinations, convulsions, coma , respiratory and metabolic acidosis, respiratory failure




Methotrexate โ†’ acute pneumonia-like syndrome, Cytopenias , mucusal ulceration



Hydroxychloroquine โ†’ skin discolouration+ eruption



Leflunomide โ†’flu-like syndrome , weight loss , alopecia, hypokalemia



Sulfasalazine โ†’ leukopenia



Adalimumab โ†’ agranulocytosis


Abatacept โ†’ upper respiratory infection


Tocilizumab+ sarilumab โ†’ hyperlipidemia, neutropenia, hypertension



Colchicine โ†’ myopathy, neutropenia, aplastic anemia, {alopecia( also hydroxychloroquine)}



Biosphonates โ†’ osteonecrosis of jaw , atypical femur fracture ,



Denosumab โ†’ Hypocalcemia , also osteonecrosis of jaw , atypical femur fracture ,


Relaxofene โ†’ leg cramps, venous thromboembolism



Teriparatide , abaloparide โ†’ hypercalcaemia , orthostatic hypotension, osteosarcoma

https://t.me/Quizpharmcy

#Antiinflammation
#DMARDs